vTv Therapeutics - שווי כולל של החברה VTVT

vTv Therapeutics Inc. (VTVT) focuses on developing anti-diabetic molecules, outsourcing production and testing to third-party contractors. This chart tracks the asset value at 12.89, while the business implements energy-saving principles and the safe disposal of reagents. Full localization of operations within the US and the humanitarian status of its developments minimize geopolitical threats and sanction risks for the company.

The development of drugs by vTv Therapeutics Inc. (VTVT) to combat metabolic disorders is reflected in the EV trend. This metric determines the actual cost of acquiring the business, accounting for debt load and liquid reserves. The calculation is based on the sum of market capitalization and liabilities minus cash and cash equivalents. For a company in the clinical trial stage, this indicator demonstrates the real value of assets prior to entering the mass market.